Terlipressin-induced vasoconstriction reversed with N-acetylcysteine: a case for combined use in hepatorenal syndrome?
Sen
Sambit
S
Mookerjee
Rajeshwar P
RP
Jalan
Rajiv
R
D000111:Acetylcysteine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006530:Hepatorenal Syndrome / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D008236:Lypressin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000077585:Terlipressin; D014661:Vasoconstriction / Q000187:drug effects*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D014662:Vasoconstrictor Agents; D008236:Lypressin; D000077585:Terlipressin; D000111:Acetylcysteine